Drug
cyproheptadine hydrochloride
cyproheptadine hydrochloride is a pharmaceutical drug with 4 clinical trials. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
2(50%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
2
50%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Terminated2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)
Trials by Status
terminated250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Effectiveness of Cyproheptadine Hydrochloride Against Appetite to Improve Children's Nutritional Status
NCT07006181
terminatedphase_3
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
NCT01132547
terminatedphase_2
Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
NCT00949117
completedphase_2
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
NCT00066248
Clinical Trials (4)
Showing 4 of 4 trials
NCT07006181Not Applicable
Effectiveness of Cyproheptadine Hydrochloride Against Appetite to Improve Children's Nutritional Status
NCT01132547Phase 3
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
NCT00949117Phase 2
Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
NCT00066248Phase 2
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4